Mr Shawn Robert Hurley, NP-C | |
9747 Caldaro St, Alta Loma, CA 91737-3577 | |
(909) 476-2190 | |
Not Available |
Full Name | Mr Shawn Robert Hurley |
---|---|
Gender | Male |
Speciality | Nurse Practitioner |
Experience | 8 Years |
Location | 9747 Caldaro St, Alta Loma, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013465202 | NPI | - | NPPES |
NP95004548 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363L00000X | Nurse Practitioner | NP95004548 (California) | Secondary |
363LF0000X | Nurse Practitioner - Family | NP95004548 (California) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
California Neurointerventional Surgeons, Inc | 2668717125 | 8 |
News Archive
Assembling a drug from harmless components at the target location, such as a tumor, would help reduce the side effects of treatment.
Seventh Sense Biosystems, Inc., an early stage, venture-backed company developing a new generation of health diagnostics products, announced today that its Touch Activated Phlebotomy™ (TAP) technology has received the Gold Medal Award from The Edison Awards™ in the Science and Medicine - Diagnostic Aids Segment. These annual awards recognize innovation, creativity and ingenuity.
Researchers from the University of Southampton, in collaboration with researchers at the University of Quebec at Montreal, have developed a new microsystem for more efficient testing of pharmaceutical drugs to treat diseases such as cystic fibrosis, MG (myasthenia gravis) and epilepsy.
Mylan Inc. today announced its financial results for the three and six months ended June 30, 2010.
› Verified 6 days ago
Entity Name | El-bershawi Medical Corp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1386813103 PECOS PAC ID: 9032298492 Enrollment ID: O20080509000414 |
News Archive
Assembling a drug from harmless components at the target location, such as a tumor, would help reduce the side effects of treatment.
Seventh Sense Biosystems, Inc., an early stage, venture-backed company developing a new generation of health diagnostics products, announced today that its Touch Activated Phlebotomy™ (TAP) technology has received the Gold Medal Award from The Edison Awards™ in the Science and Medicine - Diagnostic Aids Segment. These annual awards recognize innovation, creativity and ingenuity.
Researchers from the University of Southampton, in collaboration with researchers at the University of Quebec at Montreal, have developed a new microsystem for more efficient testing of pharmaceutical drugs to treat diseases such as cystic fibrosis, MG (myasthenia gravis) and epilepsy.
Mylan Inc. today announced its financial results for the three and six months ended June 30, 2010.
› Verified 6 days ago
Entity Name | Cep America - Neurology Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1225569346 PECOS PAC ID: 3971871500 Enrollment ID: O20170622001181 |
News Archive
Assembling a drug from harmless components at the target location, such as a tumor, would help reduce the side effects of treatment.
Seventh Sense Biosystems, Inc., an early stage, venture-backed company developing a new generation of health diagnostics products, announced today that its Touch Activated Phlebotomy™ (TAP) technology has received the Gold Medal Award from The Edison Awards™ in the Science and Medicine - Diagnostic Aids Segment. These annual awards recognize innovation, creativity and ingenuity.
Researchers from the University of Southampton, in collaboration with researchers at the University of Quebec at Montreal, have developed a new microsystem for more efficient testing of pharmaceutical drugs to treat diseases such as cystic fibrosis, MG (myasthenia gravis) and epilepsy.
Mylan Inc. today announced its financial results for the three and six months ended June 30, 2010.
› Verified 6 days ago
Entity Name | California Neurointerventional Surgeons, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417315300 PECOS PAC ID: 2668717125 Enrollment ID: O20190103000009 |
News Archive
Assembling a drug from harmless components at the target location, such as a tumor, would help reduce the side effects of treatment.
Seventh Sense Biosystems, Inc., an early stage, venture-backed company developing a new generation of health diagnostics products, announced today that its Touch Activated Phlebotomy™ (TAP) technology has received the Gold Medal Award from The Edison Awards™ in the Science and Medicine - Diagnostic Aids Segment. These annual awards recognize innovation, creativity and ingenuity.
Researchers from the University of Southampton, in collaboration with researchers at the University of Quebec at Montreal, have developed a new microsystem for more efficient testing of pharmaceutical drugs to treat diseases such as cystic fibrosis, MG (myasthenia gravis) and epilepsy.
Mylan Inc. today announced its financial results for the three and six months ended June 30, 2010.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Shawn Robert Hurley, NP-C 9747 Caldaro St, Alta Loma, CA 91737-3577 Ph: (909) 476-2190 | Mr Shawn Robert Hurley, NP-C 9747 Caldaro St, Alta Loma, CA 91737-3577 Ph: (909) 476-2190 |
News Archive
Assembling a drug from harmless components at the target location, such as a tumor, would help reduce the side effects of treatment.
Seventh Sense Biosystems, Inc., an early stage, venture-backed company developing a new generation of health diagnostics products, announced today that its Touch Activated Phlebotomy™ (TAP) technology has received the Gold Medal Award from The Edison Awards™ in the Science and Medicine - Diagnostic Aids Segment. These annual awards recognize innovation, creativity and ingenuity.
Researchers from the University of Southampton, in collaboration with researchers at the University of Quebec at Montreal, have developed a new microsystem for more efficient testing of pharmaceutical drugs to treat diseases such as cystic fibrosis, MG (myasthenia gravis) and epilepsy.
Mylan Inc. today announced its financial results for the three and six months ended June 30, 2010.
› Verified 6 days ago
Tiffany Monique Horn, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5537 Malachite Ave, Alta Loma, CA 91737 Phone: 909-560-5116 | |
Ms. Andrea Lewis, NNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4928 Clover Pl, Alta Loma, CA 91737 Phone: 909-948-5670 | |
Buchi Stella Imoohi, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6367 Puma Pl, Alta Loma, CA 91737 Phone: 909-231-9242 |